NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to Present at the H.C. Wainwright & Co. 22nd Annual Global Investment Conference
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, today announced that CEO John Climaco will present virtually at the H.C. Wainwright & Co. 22nd Annual Global Investment Conference. According to the update, Climaco’s presentation is scheduled to begin at 9:30 a.m. EDT on Wednesday, September 16, 2020, and CNSP management will hold one-on-one virtual investor meetings at the event. Interested parties may register for the presentation by visiting http://ibn.fm/3BGwC . In addition, a replay of the presentation will be available on the company's…







